Background When measles vaccines were widely introduced in the 1970s, there were concerns that they might cause subacute sclerosing panencephalitis (SSPE): a very rare, late-onset, neurological complication of natural measles infection. Therefore, SSPE registries and routine measles immunization were established in many countries concurrently. We conducted a comprehensive review of the impact of measles immunization on the epidemiology of SSPE and examined epidemiological evidence on whether there was any vaccine-associated risk. Methods Published epidemiological data on SSPE, national SSPE incidence, measles incidence and vaccine coverage, reports of SSPE in pregnancy or shortly post partum were reviewed. Potential adverse relationships be...
a<p>The estimation was based on children with SSPE diagnosis during 2003 to 2009, who had a history ...
Subacute sclerosing panencephalitis (SSPE) is a rare disorder in the developed world. However, an up...
We studied five patients with SSPE during a 10-year period (1994–2004). The first clinical symptoms ...
Since 1976, when general immunization against measles was introduced in the Netherlands, all new cas...
Background: Subacute sclerosing panencephalitis (SSPE) is a chronic central nervous (CNS) system inf...
Introduction Subacute sclerosing panencephalitis (SSPE) is a serious, late complication of measles, ...
Measles is an acute febrile exanthematous condition that is usually a self-limiting disease, but it ...
(SSPE) occurring over an 18-year period in Wales are described and used as the basis for a compariso...
Investigators conducted a retrospective epidemiological study of subacute sclerosing panencephalitis...
Purpose of the review Subacute sclerosing panencephalitis (SSPE) is a rare, slowly progressive, and ...
Subacute sclerosing panencephalitis (SSPE) is a fatal long-term complication of measles infection. W...
Subacute sclerosing panencephalitis (SSPE) is a fatal long-term complication of measles infection. W...
Introduction: Subacute sclerosing panencephalitis (SSPE) is a late, rare and usually fatal complicat...
Subacute sclerosing pan encephalitis (SSPE) is a rare neurodegenerative disorder related to a persis...
AIMS & OBJECTIVES: Sub-acute sclerosing pan-encephalitis (SSPE) is a neurological disorder caused du...
a<p>The estimation was based on children with SSPE diagnosis during 2003 to 2009, who had a history ...
Subacute sclerosing panencephalitis (SSPE) is a rare disorder in the developed world. However, an up...
We studied five patients with SSPE during a 10-year period (1994–2004). The first clinical symptoms ...
Since 1976, when general immunization against measles was introduced in the Netherlands, all new cas...
Background: Subacute sclerosing panencephalitis (SSPE) is a chronic central nervous (CNS) system inf...
Introduction Subacute sclerosing panencephalitis (SSPE) is a serious, late complication of measles, ...
Measles is an acute febrile exanthematous condition that is usually a self-limiting disease, but it ...
(SSPE) occurring over an 18-year period in Wales are described and used as the basis for a compariso...
Investigators conducted a retrospective epidemiological study of subacute sclerosing panencephalitis...
Purpose of the review Subacute sclerosing panencephalitis (SSPE) is a rare, slowly progressive, and ...
Subacute sclerosing panencephalitis (SSPE) is a fatal long-term complication of measles infection. W...
Subacute sclerosing panencephalitis (SSPE) is a fatal long-term complication of measles infection. W...
Introduction: Subacute sclerosing panencephalitis (SSPE) is a late, rare and usually fatal complicat...
Subacute sclerosing pan encephalitis (SSPE) is a rare neurodegenerative disorder related to a persis...
AIMS & OBJECTIVES: Sub-acute sclerosing pan-encephalitis (SSPE) is a neurological disorder caused du...
a<p>The estimation was based on children with SSPE diagnosis during 2003 to 2009, who had a history ...
Subacute sclerosing panencephalitis (SSPE) is a rare disorder in the developed world. However, an up...
We studied five patients with SSPE during a 10-year period (1994–2004). The first clinical symptoms ...